Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02499282
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:20 mg
-
Route of Administration:Oral
-
Colour:White to off-white
-
Shape:round
-
Markings:debossed with “851”on one side and plain on other side
- Package size:
60 Bottles - UPC Code:
063691100350 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499304
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:50 mg
-
Route of Administration:Oral
-
Colour:white to off-white
-
Shape:oval
-
Markings:debossed with “852” on one side and plain on other side
- Package size:
60 Bottles - UPC Code:
063691100350 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499312
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:70 mg
-
Route of Administration:Oral
-
Colour:white to off-white
-
Shape:round
-
Markings:debossed with “853” on one side and plain on other side
- Package size:
60 Bottles - UPC Code:
063691100374 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499320
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:80 mg
-
Route of Administration:Oral
-
Colour:White to off-white
-
Shape:triangular
-
Markings:debossed with "854" on one side and plain on other side
- Package size:
30 Bottles - UPC Code:
063691100381 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499339
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:100 mg
-
Route of Administration:Oral
-
Colour:White to off-white
-
Shape:oval
-
Markings:debossed with "855" on one side and plain on other side
- Package size:
30 Bottles - UPC Code:
063691100398 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499347
-
Active Ingredients :dasatinib
-
Innovator Name:SPRYCEL®
-
Category:Antineoplastic Agent
-
Dosage form:Film coated tablets
-
Strength:140 mg
-
Route of Administration:Oral
-
Colour:White to off-white
-
Shape:round
-
Markings:debossed with "856" on one side and plain on other side
- Package size:
30 Bottles - UPC Code:
063691100404 -
Non-medicinal ingredients :croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, colloidal silicon dioxide and dibasic calcium phosphate (film-coating - hypromellose, triacetin and titanium dioxide)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here